Tiberius (TIBR) Makes Some Changes, Sets Vote Date
by Kristi Marvin on 2020-02-20 at 11:10am

Tiberius Acquisition Corp. (TIBR), recently announced that it had made a few changes surrounding it’s business combination agreement with International General Insurance Holdings Limited (“IGI”).  In particular, TIBR announced that it had entered into another warrant purchase agreement with a holder of Tiberius’ outstanding public warrants.

WARRANT PURCHASE

Per the agreement, Tiberius will repurchase from such holder (upon closing of the business combination) 3,000,000 of Tiberius’ public warrants at a price of $1.425 per warrant, for an aggregate purchase price of $4,275,000.  This is in addition to TIBR’s agreement with Church Mutual Insurance Company (“Church”), whereby TIBR previously agreed to purchase 3,000,000 warrants at $0.75 per warrant, for an aggregate purchase price of $2,250,000.  However, of those 3,000,000 warrants, 1,500,000 are currently owned by Church, with an additional 1,500,000 to be issued at combination closing as part of their Forward Purchase Agreement with TIBR.

The new warrant purchase agreement brings the total number of warrants to be purchased by TIBR to 6,000,000.  As a reminder, TIBR has 17,250,000 public warrants outstanding (that were issued a part of the IPO units). So this new agreement is reducing that number by only 4,500,000, not 6,000,000.  The other 1,500,000 warrants are to be issued and then purchased for $0.75 at closing as part of the Forward Purchase Contract.

FOUNDER SHARES

Additionally, Tiberius also announced that its sponsor, Lagniappe Ventures LLC, has agreed to forfeit and cancel 180,000 of its shares of common stock (Founder Shares) of Tiberius upon the closing of the IGI Business Combination. TIBR held 4,312,500 Founder shares at IPO, but TIBR also previously agreed to transfer 1,039,200 Founder Shares for an earnout for the sellers.  So this new forfeit and cancellation brings TIBR’s Founder Shares total (post-close) to 3,093,300, of which, 1,973,300 are subject to an earn-out as well (based on share price hurdles).  Side note:  TIBR also previously agreed to transfer all 4,500,000 of it’s private placement warrants to the sellers.

VOTE DATE

Post this announcement from Tiberius, the share price has moved higher and most importantly, above estimated cash in trust level. TIBR has now set their shareholder vote date to complete their combination on March 13th, with a record date of February 14, 2020, so we’re coming into the home stretch. Plus, keep in mind that this transaction is already fully backstopped, so this should be a fairly straightforward vote without any hiccups. Emphasis on “should” though since we’re still dealing with the Coronavirus and its unclear yet the impact to both insurers and re-insurers.

 

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved